会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • PHOTO-LATENT TITANIUM CATALYSTS
    • 钛酸钡催化剂
    • US20120220685A1
    • 2012-08-30
    • US13395467
    • 2010-09-09
    • Tobias HintermannDidier BauerAntoine CarroyCaroline LordelotRachel Kohli Steck
    • Tobias HintermannDidier BauerAntoine CarroyCaroline LordelotRachel Kohli Steck
    • C08G18/32C09D11/10C09D175/04C08F4/76C09J175/04
    • B01J31/2234B01J31/0208B01J31/2213B01J31/2226B01J2231/34B01J2531/46C08G18/222C08G18/6216C08G18/792C09D175/04
    • The present invention provides a photolatent Ti-chelate catalyst formulation, comprising (i) at least one compound of the formula (I) wherein R1 is C1-C20alkyl or C2-C20alkyl which is interrupted by one or more non-consecutive O-atoms; Y is formula (II) or optionally substituted phenyl; Y1 is formula (III) or optionally substituted phenyl; Y2 is formula (IV) or optionally substituted phenyl; Y3 is formula (V) or optionally substituted phenyl; R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 independently of each other are hydrogen, halogen, optionally substituted C1-C20alkyl, or R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 independently of each other are optionally substituted C6-C14aryl, provided that only one of R2, R3, R4 is hydrogen and only one of R5, R6, R7 is hydrogen and only one of R8, R9, R10 is hydrogen and only one of R11, R12, R13 is hydrogen; and (ii) at least one chelate ligand compound of the formula IIa, IIb or IIc, wherein Y′ is formula (VI) or formula (VII); Y′1 is formula (VIII) or formula (IX); R′2, R′3, R′4, R′5, R′6 and R′7 independently of each other have on of the meanings as given for R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13; and R′14, R′15 and R′16 independently of each other have on of the meanings as given for R14, R15 and R16.
    • 本发明提供了一种光催化剂钛螯合催化剂制剂,其包含(i)至少一种式(I)化合物,其中R 1是被一个或多个非连续O原子间隔的C 1 -C 20烷基或C 2 -C 20烷基; Y是式(II)或任选取代的苯基; Y1是式(III)或任选取代的苯基; Y2是式(IV)或任选取代的苯基; Y 3是式(V)或任选取代的苯基; R2,R3,R4,R5,R6,R7,R8,R9,R10,R11,R12和R13彼此独立地是氢,卤素,任选取代的C 1 -C 20烷基,或者R 2,R 3,R 4,R 5,R 6,R 7 R 8,R 9,R 10,R 11,R 12和R 13彼此独立地是任选取代的C 6 -C 14芳基,条件是R 2,R 3,R 4中只有一个是氢,并且R 5,R 6,R 7中只有一个是氢, R8,R9,R10是氢,R11,R12,R13中只有一个是氢; 和(ii)式IIa,IIb或IIc的至少一种螯合配体化合物,其中Y'为式(VI)或式(VII); Y'1是式(VIII)或式(IX); R'2,R'3,R'4,R'5,R'6和R'7彼此独立地具有对R2,R3,R4,R5,R6,R7,R8,R9给出的含义 ,R10,R11,R12和R13; 并且R 14,R'15和R 16彼此独立地具有对R 14,R 15和R 16给出的含义。
    • 9. 发明授权
    • O-imino-iso-urea compounds and polymerizable compositions thereof
    • O-亚氨基异脲化合物及其可聚合组合物
    • US08664288B2
    • 2014-03-04
    • US13319244
    • 2010-05-05
    • Peter NesvadbaLucienne Bugnon FolgerAntoine CarroyMarc FallerBruno Spony
    • Peter NesvadbaLucienne Bugnon FolgerAntoine CarroyMarc FallerBruno Spony
    • C08F2/46C08J3/28C08B37/00C08F2/50B29C71/04C08G61/04
    • C08F120/18C07C251/58C07C275/70C07C2601/14C07C2601/20C08F4/00C08F8/32C09D135/02
    • The invention relates to the use of O-imino-iso-urea compounds as source of radicals to polymerizable compositions comprising these O-imino-iso-urea and to new O-imino-iso-urea compounds. The O-lmino-isoureas compounds are compounds of the Formula (I), wherein n is 1, 2, 3 or 4, R100 and R101 are independently H, C1-18 alkyl, C3-C12cycloalkyl, C6-C14aryl, C1-C14heteroaryl, C7-C15aralkyl, C2-C14heteroaralkyl, Cyano, or R100 and R101 form together with the carbon to which they are attached a mono or polycyclic C3-C18 carbocyclic or C1-C18 heterocyclic ring; R102 and R103 are independently C1-C18alkyl, C3-C12cycloalkyl, C6-C14aryl, C6-C14aryl once or more than once substituted by C1-C18alkyl; C7-C15aralkyl, (CH3)3Si—; or R102 and R103 are C1-C18alkyl, C3-C12cycloalkyl, C6-C14aryl, C7-C15aralkyl or R102 and R103 are C1-C18alkyl, C3-C12cycloalkyl which are interrupted or substituted by O or by N containing groups selected from C1-C18alkylamino, bis(C1-C18alkyl)amino or tris(C1-C18alkyl)ammonium; R104 if n is 1 is H, C1-C18alkyl, C3-C12cycloalkyl, C7-C14aralkyl, C6-C14aryl or acyl selected from the group consisting of the following acyls —C(═O)—H, —C(═O)—C1-C18alkyl, —C(═O)—C2-d18alkenyl, —C(═O)—C6-C14aryl, —C(═O)—C2-C18alkenyl-C6-C14aryl, —C(═O)—O—C1C18alkyl, —C(═O)—O—C6-C14aryl, —C(═O)—NH—C1-C18alkyl, —C(═O)—NH—C6-C14aryl and —C(═O)—N(C1C18alkyl)2; or R102 and R104 if n is 1 form together with the nitrogen atom to which they are attached a 5 to 12 membered ring which may contain additional heteroatoms, R104 if n is more than 1 is di-, tri-, tetra-C1-C18alkylidene, diacyls, triacyls or tetraacyls and salts thereof.
    • 本发明涉及O-亚氨基 - 异脲化合物作为自由基源的用途,其包含这些O-亚氨基 - 异脲和包含新的O-亚氨基 - 异脲化合物的可聚合组合物。 O - 异喹啉化合物是式(I)的化合物,其中n为1,2,3或4,R 100和R 101独立地为H,C 1-18烷基,C 3 -C 12环烷基,C 6 -C 14芳基,C 1 -C 14杂芳基 C 7 -C 15芳烷基,C 2 -C 14杂芳烷基,氰基或R 100和R 101与它们所连接的碳一起形成单或多环C 3 -C 18碳环或C 1 -C 18杂环; R 102和R 103独立地是C 1 -C 18烷基,C 3 -C 12环烷基,C 6 -C 14芳基,C 1 -C 14芳基,其一次或多于一个被C 1 -C 18烷基取代; C 7 -C 15芳烷基,(CH 3)3 Si- 或R 102和R 103为C 1 -C 18烷基,C 3 -C 12环烷基,C 6 -C 14芳基,C 7 -C 15芳烷基或R 102和R 103为C 1 -C 18烷基,C 3 -C 12环烷基,其被O或含N的基团中断或取代,所述基团选自C 1 -C 18烷基氨基, 双(C1-C18烷基)氨基或三(C1-C18烷基)铵; 如果n为1,则R 104为H,C 1 -C 18烷基,C 3 -C 12环烷基,C 7 -C 14芳烷基,C 6 -C 14芳基或选自以下酰基-C(= O)-H,-C(= O) - C 1 -C 18烷基,-C(= O)-C 2-d 18烯基,-C(= O)-C 6 -C 14芳基,-C(= O)-C 2 -C 18烯基-C 6 -C 14芳基,-C(= O) C 1 -C 18烷基,-C(= O)-O-C 6 -C 14芳基,-C(= O)-NH-C 1 -C 18烷基,-C(= O)-NHC 6 -C 14芳基和-C(= O) C 1 -C 18烷基)2; 如果n为1,则与R 102和R 104一起形成与它们所连接的氮原子一起形成可含有其它杂原子的5至12元环,如果n大于1,则R104是二 - ,三 - ,四-C1-C18亚烷基 ,二酰基,三酰基或四酰基及其盐。